Amrize Ltd
Amrize is a building solutions company focused on North America, serving infrastructure, commercial and residential construction markets, as well as repair and refurbishment projects. It sells cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building solutions to customers including home builders, commercial builders, architects and designers, distributors, contractors and government authorities. Amrize operates across the United States, Canada, Colombia, Switzerland and Jamaica, with more than 19,000 employees and more than 1,000 sites, facilities and corporate offices. Amrize has two reportable segments. Building Materials supplies cement, natural and alternative aggregates, ready-mix concrete, asphalt and other construction materials. Building Envelope offers commercial and residential roofing and wall systems, including insulation, shingles, sheathing, waterproofing, coatings, adhesives, tapes and sealants. Its brands include Duro-Last, Elevate, Malarkey, OX Engineered Products, Enverge and Gaco. Amrize makes money through sales of these products and solutions. Its principal executive offices are in Zug, Switzerland, and it also has operational headquarters in Chicago.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AMRZ in the last 30 days.
See all $AMRZ insider activity →Amrize AG (NYSE:AMRZ) reported Q3 earnings of $1.05 per share, beating estimates, but revenue of $3.77B missed expectations. Full-year guidance was lowered, citing cost inflation, sending shares down 6.9%. The company completed an acquisition and returned $1.1B to shareholders.
Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo
Amrize completed a $1 billion share-buyback program, returning $1.1 billion to shareholders. Q3 2026 revenue rose 2.2% to $3.77 billion, net income increased 3.3% to $558 million, and adjusted EBITDA grew 0.2% to $1.076 billion. The company updated FY 2026 guidance, citing cost inflation and higher interest rates. Amrize also declared a $0.11 per share dividend and completed the Rapid Redi-Mix acquisition in Dallas-Fort Worth.
Over the past 7 days, AlphAI's AI scored 6 news stories mentioning AMRZ (Amrize Ltd). Coverage has skewed bullish: 4 bullish, 0 neutral, and 2 bearish.
Recent AMRZ coverage spans financial news, earnings and corporate actions.
Guidance miss and cost inflation pressure likely drive further downside.
Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo
Amrize completed a $1 billion share-buyback program, returning $1.1 billion to shareholders. Q3 2026 revenue rose 2.2% to $3.77 billion, net income increased 3.3% to $558 million, and adjusted EBITDA grew 0.2% to $1.076 billion. The company updated FY 2026 guidance, citing cost inflation and higher interest rates. Amrize also declared a $0.11 per share dividend and completed the Rapid Redi-Mix acquisition in Dallas-Fort Worth.
Analyst target cut suggests near‑term downside pressure.
Target cut suggests further downside pressure on the stock.
AlphAI scores every news story that mentions AMRZ with an AI model for sentiment and relevance, and aggregates insider trades from Amrize Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Amrize AG (NYSE:AMRZ) reported Q3 earnings of $1.05 per share, beating estimates, but revenue of $3.77B missed expectations. Full-year guidance was lowered, citing cost inflation, sending shares down 6.9%. The company completed an acquisition and returned $1.1B to shareholders.
2 min readAmrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo
2 min readAmrize completed a $1 billion share-buyback program, returning $1.1 billion to shareholders. Q3 2026 revenue rose 2.2% to $3.77 billion, net income increased 3.3% to $558 million, and adjusted EBITDA grew 0.2% to $1.076 billion. The company updated FY 2026 guidance, citing cost inflation and higher interest rates. Amrize also declared a $0.11 per share dividend and completed the Rapid Redi-Mix acquisition in Dallas-Fort Worth.
2 min readDA Davidson lowered its price target on Amrize (NYSE:AMRZ) to $40 from $50, citing concerns about fiscal 2026 guidance and the recent departure of a key executive. The stock is trading at $36.31, down 45% from its 52-week high. Multiple analysts have recently adjusted their price targets and ratings on Amrize, reflecting mixed outlooks ahead of its earnings release.
2 min readRBC Capital cut Amrize's (AMRZ) price target to $32 from $48, citing cost concerns and C-suite turnover. The stock is near its 52-week low, down 36% in six months. Multiple analysts have adjusted targets and ratings, reflecting cautious near-term outlooks. Amrize reports Q3 earnings on October 26, 2026.
2 min readBofA downgraded Amrize (NYSE:AMRZ) to Underperform, cutting its price target to $40 from $50. The firm cited growth concerns, including risks to U.S. cement prices, Canada macro conditions, and hurricane season impacts. Amrize's stock is down 30% year-to-date, trading at $37.25. Other analysts have also adjusted their price targets and ratings.
2 min readAmrize Ltd's average stock price target was reduced from $52.37 to $52.04 by 24 analysts, with a range of $40 to $65. This implies a 39% upside from the September 30 closing price. The consensus rating remains 'Buy' among 28 analysts.
1 min readBarclays initiated coverage on Amrize Ltd (NYSE:AMRZ) with an Equalweight rating and a $55 price target. The stock trades at $37.39, near its 52-week low. Barclays cited lower U.S. aggregates exposure and near-term challenges. Multiple analysts have adjusted price targets and ratings, citing weak earnings and cost pressures.
2 min readOppenheimer kept its Outperform rating on Amrize, setting a $55 price target, suggesting a 44% upside from the recent $38.19 close. The firm cited Amrize's strong market position in North American construction, particularly in data centers, and its growth prospects driven by capacity enhancements and M&A.
1 min readAmrize (SWX:AMRZ) appointed Mario Gross as President of its Building Envelope division following Jake Gosa's resignation. The company's shares trade at CHF32.07, down 15.3% over the past month and 28.5% over the last quarter. Analysts suggest a fair value of CHF46.66, citing potential earnings power and margin expansion from the ASPIRE synergy program. The P/E ratio is 17.3x, compared to an estimated fair ratio of 30.5x and a peer average of 48.6x.
2 min read
